A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening

OH Ajetunmobi, G Wall, BV Bonifacio… - … : Methods and Protocols, 2023 - Springer
Candidiasis, infections caused by Candida spp., represents one of the most common
nosocomial infections afflicting an expanding number of compromised patients. Antifungal …

A Method for the Formation of Candida Biofilms in 96 Well Microtiter Plates and Its Application to Antifungal Susceptibility Testing

CG Pierce, P Uppuluri, JL Lopez-Ribot - Laboratory Protocols in Fungal …, 2013 - Springer
Fungal infections are an increasing threat to an expanding population of
immunocompromised patients. Of these, candidiasis remains the most common, now …

Techniques for Antifungal Susceptibility Testing of Candida albicans Biofilms

G Ramage, JL López-Rib - Antifungal Agents: Methods and Protocols, 2005 - Springer
Candida albicans is capable of forming biofilms on a variety of inert and biological surfaces.
Cells in biofilms display phenotypic properties that are radically different from their free …

[HTML][HTML] A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms

CG Pierce, P Uppuluri, S Tummala… - Journal of visualized …, 2010 - ncbi.nlm.nih.gov
Candida albicans remains the most frequent cause of fungal infections in an expanding
population of compromised patients and candidiasis is now the third most common infection …

A novel robust method mimicking human substratum to dissect the heterogeneity of Candida auris biofilm formation

B Biswas, A Rana, N Gupta, I Gupta, R Puria… - Microbiology …, 2023 - Am Soc Microbiol
Candida auris is a pathogen of urgent threat level as marked by the CDC. The formation of
biofilms is an essential property of this fungus to establish infection and escape drug …

Biofilm formation studies in microtiter plate format

M Riera, E Moreno-Ruiz, S Goyard, C d'Enfert… - … : Methods and Protocols, 2012 - Springer
Although Candida biofilms have been clearly identified as playing an increasingly important
role in human disease, their biology and the reason for their poor susceptibility to antifungal …

Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs

D Romera, JJ Aguilera-Correa… - Journal of medical …, 2019 - microbiologyresearch.org
Introduction. Candida auris is a pathogenic yeast that mainly affects immunosuppressed
patients and those with implanted medical devices. This pathogen also displays elevated …

Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms

G Ramage, K Vande Walle, BL Wickes… - Antimicrobial agents …, 2001 - Am Soc Microbiol
Candida albicans is implicated in many biomaterial-related infections. Typically, these
infections are associated with biofilm formation. Cells in biofilms display phenotypic traits …

[HTML][HTML] Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening

A Srinivasan, JL Lopez-Ribot… - Journal of visualized …, 2012 - ncbi.nlm.nih.gov
Candida albicans remains the main etiological agent of candidiasis, which currently
represents the fourth most common nosocomial bloodstream infection in US hospitals 1 …

Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms

EI Nweze, A Ghannoum, J Chandra… - Journal of …, 2012 - academic.oup.com
Background Candida biofilms, which are often associated with device-related infections,
including catheter-related bloodstream infections, are resistant to commonly used antifungal …